Oncovation Laboratories is an innovative laboratory services company focusing on oncology.

The Diagnostics Group provides patients as well as medical and surgical oncologists with patient-specific tumor information that allows the oncologist to select and, if necessary, devise individualized treatment protocols. The TCR Assay(^tm) optimizes and uncovers the most advantageous treatment regimen within standard regimens and when there is no available standard regimen, selects among the best of available research.

The Clinical Services group offers pre-clinical and Phase I-IV drug development services to the global pharmaceutical and biotechnology industries. Our capabilities include drug development planning, protocol design, submission services, regulatory affairs consulting, investigator and patient recruitment, data management, statistics and medical writing. We can help enrich the patient population and success rate in clinical trials and expand the therapeutic options after approval of the drug. Oncovation can speed current trials and expand them by turning predictable empirical failures into successfully treated patients.